April 11, 2025 C-Path Launches Newest Podcast Episode: Connecting the Dots Between T1D and Parkinson’s In our latest episode of the C-Path podcast, “Connecting the Dots Between Type 1 Diabetes and Parkinson’s Disease,” we...
April 2, 2025 C-Path’s Stephenson Appears on Xtalks’ Life Science Podcast to Talk Future of Drug Development in Parkinson’s, Alzheimer’s C-Path's Diane Stephenson recently appeared on the Xtalks Life Science Podcast...
The Critical Path Institute Podcast: Connecting the Dots with COA VP Dr. Cheryl Coon If you have attended one of C-Path’s stakeholder meetings, read one of our impact stories or engaged through our social...
February 19, 2025 Advancing Neonatal Drug Development Through Collaboration At C-Path’s INC, we believe that meaningful progress in neonatal drug development...
February 19, 2025 C-Path’s eCOA Consortium Welcomes Veeva Systems and VPG Health as Newest Partners C-Path's eCOA Consortium is thrilled to welcome Veeva Systems and VPG Health...
February 18, 2025 C-Path’s CPA-1 Consortium Welcomes Newest Members Kamada, Sanofi Critical Path for Alpha-1 (CPA-1) consortium today announced the addition of biopharmaceutical companies, Kamada and Sanofi.
February 20, 2025 Vivli and RDCA-DAP Present: Data Platform Partnerships to promote Rare Disease Data Sharing Join Julie Wood, Chief Operating Officer at Vivli, for an engaging webinar, Thursday, February 20, where she’ll discuss...
January 7, 2025 Inclusion in neurological research: empowering people living with neurological diseases The value of involving people living with diseases in the research process is increasingly recognized...
November 27, 2024 Voice of the Patient report Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting for ARPKD Patients and their Families Autosomal Recessive Polycystic Kidney Disease (ARPKD) is a rare genetic disease. It occurs in about one in 20,000 births...
December 12, 2024 Investigating item response theory model performance in the context of evaluating clinical outcome assessments in clinical trials Item response theory (IRT) models are an increasingly popular method choice for...
